Inspiration meets innovation at Brandweek, the ultimate marketing experience. Join industry luminaries, rising talent and strategic experts in Phoenix, Arizona this September 23–26 to assess challenges, develop solutions and create new pathways for growth. Register early to save.
ATLANTA Rockett, Burkhead & Winslow has added Salix Pharmaceuticals to its client roster, the agency said.
The specialty pharmaceutical company focuses on prescription drugs for gastrointestinal disorders. The shop will market and advertise Colazal, an anti-inflammatory drug used to treat ulcerative colitis.
According to RB&W, Colazal will be Salix’s first generally marketed product. The agency also will assist the firm in the continued development and advertising campaign for Rifaximin, a non-systemic antibiotic intended for gastrointestinal tract infections.
“RB&W
WORK SMARTER - LEARN, GROW AND BE INSPIRED.
Subscribe today!
To Read the Full Story Become an Adweek+ Subscriber
Already a member? Sign in